The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency*
Abstract
More than 90% of cases of congenital adrenal hyperplasia (CAH, the inherited inability to synthesize cortisol) are caused by 21-hydroxylase deficiency. Females with severe, classic 21-hydroxylase deficiency are exposed to excess androgens prenatally and are born with virilized external genitalia. Most patients cannot synthesize sufficient aldosterone to maintain sodium balance and may develop potentially fatal “salt wasting” crises if not treated. The disease is caused by mutations in the CYP21 gene encoding the steroid 21-hydroxylase enzyme. More than 90% of these mutations result from intergenic recombinations between CYP21 and the closely linked CYP21P pseudogene. Approximately 20% are gene deletions due to unequal crossing over during meiosis, whereas the remainder are gene conversions—transfers to CYP21 of deleterious mutations normally present in CYP21P. The degree to which each mutation compromises enzymatic activity is strongly correlated with the clinical severity of the disease in patients carrying it. Prenatal diagnosis by direct mutation detection permits prenatal treatment of affected females to minimize genital virilization. Neonatal screening by hormonal methods identifies affected children before salt wasting crises develop, reducing mortality from this condition. Glucocorticoid and mineralocorticoid replacement are the mainstays of treatment, but more rational dosing and additional therapies are being developed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, population-based studies continue to reveal rare or population-specific alleles, highlighting the extensive allelic heterogeneity of 21-OHD and the necessity of using ethnically tailored genetic panels for accurate diagnosis and effective genetic counseling (5, 16, 19, 22, 28, 33–35).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [5]
In the citing paper
“Among these, microconversion events, in which one or more deleterious pseudogene-derived variants are transferred into CYP21A2 during meiosis, represent 70–75% of all cases (5, 16, 19, 20).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [5]
In the citing paper
“In contrast, only 5-10% of small pathogenic variants in CYP21A2 occur independently of gene conversion events; some of these have founder effects, providing valuable insights into population history and migration patterns (5, 16, 19–22).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [5]
In the citing paper
“The remaining 20–25% are attributable to unequal meiotic crossovers, giving rise to extensive genomic rearrangements, including large deletions, duplications, and the formation of chimeric CYP21A1P/CYP21A2 genes.”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [5]
In the citing paper
“Approximately 90-99% of cases of CAH are caused by 21-hydroxylase deficiency (21OHD) caused by mutations in the CYP21A2 gene (1,2); the terms CAH and 21OHD will be used interchangeably in this article.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [1]
In the citing paper
“In 21OHD, 17OHP, the steroid before 21-hydroxylase, accumulates and is traditionally used to diagnose 21OHD (1,134,135).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [1]
Citations
Cites
Regulation of the acute production of steroids in steroidogenic cells
STOCCO, D. M., & CLARK, B. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-221 · Cited by 1,057
Steroidogenic factor 1: a key determinant of endocrine development and function
Parker, K. L., & Schimmer, B. P. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0301 · Cited by 764
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Self-citationStructure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
Self-citationPang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
Carroll, M. C., Campbell, R. D., & Porter, R. R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.521 · Cited by 370
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Research works printed but not linked: 468
- Bongiovanni, 1963, The adrenogenital syndrome., N Engl J Med, 268, 1283, 10.1056/NEJM196306062682308 · DOI
- White, 1984, HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation., Proc Natl Acad Sci USA, 81, 7505, 10.1073/pnas.81.23.7505 · DOI · Paper page
- White, 1987, Congenital adrenal hyperplasia (1)., N Engl J Med, 316, 1519, 10.1056/NEJM198706113162406 · DOI
- White, 1987, Congenital adrenal hyperplasia (2)., N Engl J Med, 316, 1580, 10.1056/NEJM198706183162506 · DOI
- Morel, 1991, Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency., Adv Hum Genet, 20, 1
- Arakane, 1998, The mechanism of action of steroidogenic acute regulatory protein (StAR). StAR acts on the outside of mitochondria to stimulate steroidogenesis., J Biol Chem, 273, 16339, 10.1074/jbc.273.26.16339 · DOI
- Papadopoulos, 1998, Structure and function of the peripheral-type benzodiazepine receptor in steroidogenic cells., Proc Soc Exp Biol Med, 217, 130, 10.3181/00379727-217-44215 · DOI
- White, 1994, Genetic diseases of steroid metabolism., Vitam Horm, 49, 131, 10.1016/S0083-6729(08)61147-4 · DOI
- Nebert, 1991, The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature [published erratum appears in DNA Cell Biol 1991 Jun; 10(5):397–8]., DNA Cell Biol, 10, 1, 10.1089/dna.1991.10.1 · DOI
- Rheaume, 1991, Structure and expression of a new cDNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/δ5-δ4 isomerase in human adrenals and gonads., Mol Endocrinol, 5, 1147, 10.1210/mend-5-8-1147 · DOI · Paper page
- Yanase, 1991, 17α-Hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition., Endocr Rev, 12, 91, 10.1210/edrv-12-1-91 · DOI · Paper page
- Penning, 1997, Molecular endocrinology of hydroxysteroid dehydrogenases., Endocr Rev, 18, 281
- Simpson, 1994, Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis., Endocr Rev, 15, 342
- Wilson, 1993, Steroid 5α-reductase 2 deficiency., Endocr Rev, 14, 577
- Bertagna, 1994, Proopiomelanocortin-derived peptides., Endocrinol Metab Clin North Am, 23, 467, 10.1016/S0889-8529(18)30079-3 · DOI
- Mountjoy, 1992, The cloning of a family of genes that encode the melanocortin receptors., Science, 257, 1248, 10.1126/science.1325670 · DOI · Paper page
- Waterman, 1997, Cytochromes P450 12: diversity of ACTH (cAMP)-dependent transcription of bovine steroid hydroxylase genes., FASEB J, 11, 419, 10.1096/fasebj.11.6.9194522 · DOI
- Orth, 1995, Cushing’s syndrome [published erratum appears in N Engl J Med 1995 Jun 1;332(22):1527]., N Engl J Med, 332, 791, 10.1056/NEJM199503233321207 · DOI
- Itoi, 1998, Cellular and extracellular regulatory mechanisms of hypothalamic corticotropin-releasing hormone neurons., Endocr J, 45, 13, 10.1507/endocrj.45.13 · DOI
- Scott, 1998, Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression., Life Sci, 62, 1985, 10.1016/S0024-3205(98)00027-7 · DOI
- Nussdorfer, 1998, Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis., Peptides, 19, 1443, 10.1016/S0196-9781(98)00102-8 · DOI
- Evans, 1989, A molecular framework for the actions of glucocorticoid hormones in the nervous system., Neuron, 2, 1105, 10.1016/0896-6273(89)90177-3 · DOI
- Carsia, 1983, Glucocorticoid control of steroidogenesis in isolated rat adrenocortical cells., Biochim Biophys Acta, 763, 83, 10.1016/0167-4889(83)90028-9 · DOI
- Reincke, 1998, Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex., J Endocrinol, 156, 415, 10.1677/joe.0.1560415 · DOI
- Rainey, 1998, Functional adrenal zonation and regulation of aldosterone biosynthesis., Curr Opin Endocrinol Diab, 5, 175, 10.1097/00060793-199806000-00005 · DOI
- Matsusaka, 1997, Biological functions of angiotensin and its receptors., Annu Rev Physiol, 59, 395, 10.1146/annurev.physiol.59.1.395 · DOI
- Barrett, 1989, Role of calcium in angiotensin II-mediated aldosterone secretion., Endocr Rev, 10, 496, 10.1210/edrv-10-4-496 · DOI · Paper page
- de Peretti, 1982, Pitfalls in the etiological diagnosis of congenital adrenal hyperplasia in the early neonatal period., Horm Res, 16, 10, 10.1159/000179480 · DOI
- Frank, 1997, Near-fatal misdiagnosis of congenital adrenal hyperplasia., J Pediatr, 131, 165, 10.1016/S0022-3476(97)70146-X · DOI
- Speiser, 1987, Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency., J Clin Endocrinol Metab, 64, 86, 10.1210/jcem-64-1-86 · DOI
- Witchel, 1998, Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests., Am J Med Genet, 76, 337, 10.1002/(SICI)1096-8628(19980401)76:4<337::AID-AJMG9>3.0.CO;2-M · DOI
- Lejeune-Lenain, 1980, An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia., Clin Endocrinol (Oxf), 12, 525, 10.1111/j.1365-2265.1980.tb01372.x · DOI
- Gourmelen, 1987, Detection of heterozygous carriers for 21-hydroxylase deficiency by plasma 21-deoxycortisol measurement., Acta Endocrinol (Copenh), 116, 507, 10.1530/acta.0.1160507 · DOI
- Fiet, 1988, Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia., J Clin Endocrinol Metab, 66, 659, 10.1210/jcem-66-4-659 · DOI · Paper page
- Fiet, 1994, The application of a new highly-sensitive radioimmunoassay for plasma 21-deoxycortisol to the detection of steroid-21-hydroxylase deficiency., Ann Clin Biochem, 31, 56, 10.1177/000456329403100110 · DOI
- Swain, 1998, Dax1 antagonizes Sry action in mammalian sex determination., Nature, 391, 761, 10.1038/35799 · DOI
- Parker, 1999, Gene interactions in gonadal development., Annu Rev Physiol, 61, 417, 10.1146/annurev.physiol.61.1.417 · DOI
- Vainio, 1999, Female development in mammals is regulated by Wnt-4 signaling., Nature, 397, 405, 10.1038/17068 · DOI
- Lee, 1993, Mullerian inhibiting substance: a gonadal hormone with multiple functions., Endocr Rev, 14, 152
- Quigley, 1995, Androgen receptor defects: historical, clinical, and molecular perspectives [published erratum appears in Endocr Rev 1995 Aug;16(4):546]., Endocr Rev, 16, 271
- Villee, 1972, The development of steroidogenesis., Am J Med, 53, 533, 10.1016/0002-9343(72)90151-9 · DOI
- Siiteri, 1966, Placental estrogen biosynthesis during human pregnancy., J Clin Endocrinol Metab, 26, 751, 10.1210/jcem-26-7-751 · DOI · Paper page
- Mesiano, 1997, Developmental and functional biology of the primate fetal adrenal cortex., Endocr Rev, 18, 378
- Muscatelli, 1994, Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism., Nature, 372, 672, 10.1038/372672a0 · DOI
- Bocian-Sobkowska, 1997, Comparative stereological study on zonation and cellular composition of adrenal glands of normal and anencephalic human fetuses. I. Zonation of the gland., Histol Histopathol, 12, 311
- Bryan, 1988, Ultrasound findings in the adreno-genital syndrome (congenital adrenal hyperplasia)., J Ultrasound Med, 7, 675, 10.7863/jum.1988.7.12.675 · DOI
- Al-Alwan, 1999, Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia., J Pediatr, 135, 71, 10.1016/S0022-3476(99)70330-6 · DOI
- Reiter, 1977, Secretion of the adrenal androgen, dehydroepiandrosterone sulfate, during normal infancy, childhood, and adolescence, in sick infants, and in children with endocrinologic abnormalities., J Pediatr, 90, 766, 10.1016/S0022-3476(77)81244-4 · DOI
- Sellers, 1995, Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency., Endocr Res, 21, 537, 10.1080/07435809509030471 · DOI
- Brunelli, 1995, Adrenarche does not occur in treated patients with congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency., Clin Endocrinol (Oxf), 42, 461, 10.1111/j.1365-2265.1995.tb02663.x · DOI
- Jost, 1970, Hormonal factors in the sex differentiation of the mammalian foetus., Philos Trans R Soc Lond B Biol Sci, 259, 119, 10.1098/rstb.1970.0052 · DOI · Paper page
- Winters, 1996, Female pseudohermaphroditism due to congenital adrenal hyperplasia complicated by adenocarcinoma of the prostate and clear cell carcinoma of the endometrium., Am J Clin Pathol, 106, 660, 10.1093/ajcp/106.5.660 · DOI
- Grumbach, 1960, The effects of androgens on fetal sexual development. Androgen-induced female pseudohermaphroditism., Fertil Steril, 11, 157, 10.1016/S0015-0282(16)33722-0 · DOI
- Prader, 1954, Der genitalbefund beim ppseudohermaphroditismus femininus der kengenitalen adrenogenitalen syndroms., Helv Paediatr Acta, 9, 231
- Choong, 1996, Reduced androgen receptor gene expression with first exon CAG repeat expansion., Mol Endocrinol, 10, 1527
- Chamberlain, 1994, The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function., Nucl Acids Res, 22, 3181, 10.1093/nar/22.15.3181 · DOI
- Jaaskelainen, 1997, Growth of patients with 21 hydroxylase deficiency: an analysis of the factors influencing adult height., Pediatr Res, 41, 3033, 10.1203/00006450-199701000-00005 · DOI
- Belgorosky, 1996, Elevation of serum luteinizing hormone levels during hydrocortisone treatment in infant girls with 21-hydroxylase deficiency., Acta Paediatr, 85, 1172, 10.1111/j.1651-2227.1996.tb18223.x · DOI
- Barnes, 1994, Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women., J Clin Endocrinol Metab, 79, 1328
- Funder, 1993, Aldosterone action., Annu Rev Physiol, 55, 115, 10.1146/annurev.ph.55.030193.000555 · DOI
- Lamberts, 1997, Corticosteroid therapy in severe illness., N Engl J Med, 337, 1285, 10.1056/NEJM199710303371807 · DOI
- Globerman, 1988, An inherited defect in aldosterone biosynthesis caused by a mutation in or near the gene for steroid 11-hydroxylase., N Engl J Med, 319, 1193, 10.1056/NEJM198811033191804 · DOI
- Berger, 1996, Analysis of glucocorticoid and mineralocorticoid signalling by gene targeting., Endocr Res, 22, 641, 10.1080/07435809609043758 · DOI
- Kuhnle, 1986, Evidence for the secretion of an antimineralocorticoid in congenital adrenal hyperplasia., J Clin Endocrinol Metab, 62, 934, 10.1210/jcem-62-5-934 · DOI
- Wambach, 1978, Antimineralocorticoid action of progesterone in the rat: correlation of the effect on electrolyte excretion and interaction with renal mineralocorticoid receptors., Endocrinology, 102, 1686, 10.1210/endo-102-6-1686 · DOI
- Losert, 1985, Progestogens with antimineralocorticoid activity., Arzneimittelforschung, 35, 459
- Rafestin-Oblin, 1991, Renal action of progesterone and 18-substituted derivatives, Am J Physiol, 260, F828
- Whitehead, 1996, Dehydration deaths in infants and young children., Am J Forensic Med Pathol, 17, 73, 10.1097/00000433-199603000-00014 · DOI
- Rebuffat, 1988, Further investigations on the atrial natriuretic factor (ANF)-induced inhibition of the growth and steroidogenic capacity of rat adrenal zona glomerulosa in vivo., J Steroid Biochem, 29, 605, 10.1016/0022-4731(88)90158-6 · DOI
- Stoner, 1986, Is salt-wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect?, Clin Endocrinol (Oxf), 24, 9, 10.1111/j.1365-2265.1986.tb03249.x · DOI · Paper page
- Speiser, 1991, Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase., N Engl J Med, 324, 145, 10.1056/NEJM199101173240302 · DOI
- Winkel, 1983, Extraadrenal steroid 21-hydroxylase activity in a woman with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency., J Clin Endocrinol Metab, 56, 104, 10.1210/jcem-56-1-104 · DOI
- Lajic, 1995, Steroid 21-hydroxylase in the kidney: demonstration of levels of messenger RNA which correlate with the level of activity., J Steroid Biochem Mol Biol, 52, 181, 10.1016/0960-0760(94)00158-I · DOI
- Zhou, 1997, Steroid 21-hydroxylase expression and activity in human lymphocytes., Mol Cell Endocrinol, 127, 11, 10.1016/S0303-7207(96)03997-4 · DOI · Paper page
- Zhou, 1998, Prominent sex steroid metabolism in human lymphocytes., Mol Cell Endocrinol, 138, 61, 10.1016/S0303-7207(98)00052-5 · DOI
- Tukey, 1985, Multiple gene-like sequences related to the rabbit hepatic progesterone 21-hydroxylase cytochrome P-450 1., J Biol Chem, 260, 13347, 10.1016/S0021-9258(17)38876-2 · DOI
- Thilen, 1995, Early growth is not increased in untreated moderately severe 21-hydroxylase deficiency., Acta Paediatr, 84, 894, 10.1111/j.1651-2227.1995.tb13788.x · DOI
- Legro, 1994, Size polymorphisms of the androgen receptor among female hispanics and correlation with androgenic characteristics., Obstet Gynecol, 83, 701
- Klingensmith, 1977, Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility., J Pediatr, 90, 996, 10.1016/S0022-3476(77)80581-7 · DOI
- Young, 1989, Growth and body proportions in congenital adrenal hyperplasia., Arch Dis Child, 64, 1554, 10.1136/adc.64.11.1554 · DOI
- David, 1994, [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency]. [French]., Arch Pediatr, 1, 363
- Lim, 1995, Adrenal 21-hydroxylase deficiency in childhood: 25 years’ experience., J Paediatr Child Health, 31, 222, 10.1111/j.1440-1754.1995.tb00790.x · DOI
- Hauffa, 1997, Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency., Klin Padiatr, 209, 71, 10.1055/s-2008-1043931 · DOI
- Odell, 1984, Control of adrenal androgen production., Endocr Res, 10, 617, 10.1080/07435808409036520 · DOI
- London, 1987, The consequences of hyperandrogenism in young women., J R Soc Med, 80, 741, 10.1177/014107688708001206 · DOI
- Bonaccorsi, 1987, Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients., Fertil Steril, 47, 664, 10.1016/S0015-0282(16)59119-5 · DOI
- Holmes-Walker, 1995, Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency., Clin Endocrinol (Oxf), 43, 291, 10.1111/j.1365-2265.1995.tb02034.x · DOI · Paper page
- Imperato-McGinley, 1986, Nipple differentiation in fetal male rats treated with an inhibitor of the enzyme 5 α-reductase: definition of a selective role for dihydrotestosterone., Endocrinology, 118, 132, 10.1210/endo-118-1-132 · DOI
- Pertzelan, 1982, A comparative study of the effect of oestrogen substitution therapy on breast development in girls with hypo and hypergonadotrophic hypogonadism., Clin Endocrinol (Oxf), 16, 359, 10.1111/j.1365-2265.1982.tb00728.x · DOI
- Schwarz, 1995, Rapid occurrence of thelarche and menarche induced by hydrocortisone in a teenage girl with previously untreated congenital adrenal hyperplasia., Eur J Pediatr, 154, 617, 10.1007/BF02079062 · DOI
- Lo, 1999, Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency., J Clin Endocrinol Metab, 84, 930
- Miller, 1999, Congenital adrenal hyperplasia in the adult patient., Adv Intern Med, 44, 155
- Kerlan, 1994, Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy., Clin Endocrinol (Oxf), 40, 263, 10.1111/j.1365-2265.1994.tb02478.x · DOI · Paper page
- Dorfman, 1999, The antiestrogenic and antiandrogenic effects of progesterone in the defense of a normal fetus., Anat Rec, 157, 547, 10.1002/ar.1091570402 · DOI
- Urban, 1978, Adult height and fertility in men with congenital virilizing adrenal hyperplasia., N Engl J Med, 299, 1392, 10.1056/NEJM197812212992505 · DOI
- Prader, 1973, Fertility in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency., Acta EndocrinolCopenh [Suppl], 177, 57
- Willi, 1991, Testicular adrenal-like tissue (TALT) in congenital adrenal hyperplasia: detection by ultrasonography., Pediatr Radiol, 21, 284, 10.1007/BF02018626 · DOI
- Rutgers, 1988, The testicular “tumor” of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders., Am J Surg Pathol, 12, 503, 10.1097/00000478-198807000-00001 · DOI
- Sinforiani, 1994, Cognitive and neuroradiological findings in congenital adrenal hyperplasia., Psychoneuroendocrinology, 19, 55, 10.1016/0306-4530(94)90059-0 · DOI
- Nass, 1991, Learning disabilities in children with congenital adrenal hyperplasia., J Child Neurol, 6, 306, 10.1177/088307389100600404 · DOI · Paper page
- Helleday, 1994, General intelligence and cognitive profile in women with congenital adrenal hyperplasia (CAH)., Psychoneuroendocrinology, 19, 343, 10.1016/0306-4530(94)90015-9 · DOI
- Resnick, 1986, Early hormonal influences on cognitive functioning in congenital adrenal hyperplasia., Dev Psychol, 22, 191, 10.1037/0012-1649.22.2.191 · DOI
- Nass, 1991, Androgen effects on cognition: congenital adrenal hyperplasia., Psychoneuroendocrinology, 16, 189, 10.1016/0306-4530(91)90078-8 · DOI
- Hampson, 1998, Spatial reasoning in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency., Dev Neuropsychol, 14, 299, 10.1080/87565649809540713 · DOI
- Nass, 1987, Hormones and handedness: left-hand bias in female congenital adrenal hyperplasia patients., Neurology, 37, 711, 10.1212/WNL.37.4.711 · DOI
- Helleday, 1994, Normal lateralization for handedness and ear advantage in a verbal dichotic listening task in women with congenital adrenal hyperplasia (CAH)., Neuropsychologia, 32, 875, 10.1016/0028-3932(94)90024-8 · DOI
- Plante, 1996, Elevated androgen, brain development and language/learning disabilities in children with congenital adrenal hyperplasia., Dev Med Child Neurol, 38, 423, 10.1111/j.1469-8749.1996.tb15100.x · DOI
- Ehrhardt, 1981, Effects of prenatal sex hormones on gender-related behavior., Science, 211, 1312, 10.1126/science.7209510 · DOI
- Breedlove, 1994, Sexual differentiation of the human nervous system., Annu Rev Psychol, 45, 389, 10.1146/annurev.ps.45.020194.002133 · DOI
- Meyer-Bahlburg, 1999, What causes low rates of child-bearing in congenital adrenal hyperplasia?, J Clin Endocrinol Metab, 84, 1844, 10.1210/jcem.84.6.5718 · DOI · Paper page
- Meyer-Bahlburg, 1999, Gender assignment and reassignment in 46, XY pseudohermaproditism and related conditions., J Clin Endocrinol Metab, 84, 3455, 10.1210/jcem.84.10.6099 · DOI
- Dittmann, 1990, Congenital adrenal hyperplasia. I: Gender-related behavior and attitudes in female patients and sisters[ published erratum appears in Psychoneuroendocrinology 1991;16(4):369–71]., Psychoneuroendocrinology, 15, 401, 10.1016/0306-4530(90)90065-H · DOI
- Dittmann, 1990, Congenital adrenal hyperplasia. II. Gender-related behavior and attitudes in female salt-wasting and simple-virilizing patients., Psychoneuroendocrinology, 15, 421, 10.1016/0306-4530(90)90066-I · DOI
- Berenbaum, 1995, Early hormonal influences on childhood sex-typed activity and playmate preferences: implications for the development of sexual orientation., Dev Psychol, 31, 31, 10.1037/0012-1649.31.1.31 · DOI
- Berenbaum, 1999, Effects of early androgens on sex-typed activities and interests in adolescents with congenital adrenal hyperplasia., Horm Behav, 35, 102, 10.1006/hbeh.1998.1503 · DOI
- Dittmann, 1992, Body positions and movement patterns in female patients with congenital adrenal hyperplasia., Horm Behav, 26, 441, 10.1016/0018-506X(92)90013-L · DOI
- Berenbaum, 1997, Early androgen effects on aggression in children and adults with congenital adrenal hyperplasia., Psychoneuroendocrinology, 22, 505, 10.1016/S0306-4530(97)00049-8 · DOI
- Helleday, 1993, Personality characteristics and platelet MAO activity in women with congenital adrenal hyperplasia (CAH)., Psychoneuroendocrinology, 18, 343, 10.1016/0306-4530(93)90010-I · DOI
- Gordon, 1986, Behavioral problems, social competency, and self perception among girls with congenital adrenal hyperplasia., Child Psychiatry Hum Dev, 17, 129, 10.1007/BF00706652 · DOI
- Hurtig, 1987, Psychological findings in early treated cases of female pseudohermaphroditism caused by virilizing congenital adrenal hyperplasia., Arch Sex Behav, 16, 209, 10.1007/BF01541609 · DOI
- Money, 1984, Adult erotosexual status and fetal hormonal masculinization and demasculinization: 46,XX congenital virilizing adrenal hyperplasia and 46,XY androgen-insensitivity syndrome compared., Psychoneuroendocrinology, 9, 405, 10.1016/0306-4530(84)90048-9 · DOI
- Dittmann, 1992, Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia., Psychoneuroendocrinology, 17, 153, 10.1016/0306-4530(92)90054-B · DOI
- Zucker, 1996, Psychosexual development of women with congenital adrenal hyperplasia., Horm Behav, 30, 300, 10.1006/hbeh.1996.0038 · DOI
- Bradley, 1998, Experiment of nurture: ablatio penis at 2 months, sex reassignment at 7 months, and a psychosexual follow-up in young adulthood, Pediatrics, 102, e9, 10.1542/peds.102.1.e9 · DOI
- Diamond, 1999, Pediatric management of ambiguous and traumatized genitalia., J Urol, 162, 1, 10.1016/S0022-5347(01)68054-6 · DOI
- Bosinski, 1997, A higher rate of hyperandrogenic disorders in female-to-male transsexuals., Psychoneuroendocrinology, 22, 361, 10.1016/S0306-4530(97)00033-4 · DOI
- Slijper, 1998, Long-term psychological evaluation of intersex children., Arch Sex Behav, 27, 125, 10.1023/A:1018670129611 · DOI
- Meyer-Bahlburg, 1996, Gender change from female to male in classical congenital adrenal hyperplasia., Horm Behav, 30, 319, 10.1006/hbeh.1996.0039 · DOI
- Abdullah, 1991, Ambiguous genitalia: medical, socio-cultural and religious factors affecting management in Saudi Arabia., Ann Trop Paediatr, 11, 343, 10.1080/02724936.1991.11747526 · DOI
- Chatterjee, 1992, Congenital adrenal hyperplasia: experience at Calcutta., Indian Pediatr, 29, 1013
- Kandemir, 1997, Congenital adrenal hyperplasia in Turkey: a review of 273 patients., Acta Paediatr, 86, 22, 10.1111/j.1651-2227.1997.tb08824.x · DOI
- Hochberg, 1987, Psychosexual outcome of assigned females and males with 46,XX virilizing congenital adrenal hyperplasia., Eur J Pediatr, 146, 497, 10.1007/BF00441602 · DOI
- Bernini, 1996, 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas., J Endocrinol Invest, 19, 745, 10.1007/BF03347878 · DOI
- Beuschlein, 1998, Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors., J Clin Endocrinol Metab, 83, 2585
- Jaresch, 1992, Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia., J Clin Endocrinol Metab, 74, 685
- Ravichandran, 1996, Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency., J Clin Endocrinol Metab, 81, 1776
- Umpierrez, 1997, Adrenal myelolipoma associated with endocrine dysfunction: review of the literature., Am J Med Sci, 314, 338
- Pignatelli, 1998, Adrenal incidentalomas: adrenal hemangioma in a patient with congenital adrenal hyperplasia., South Med J, 91, 775, 10.1097/00007611-199808000-00018 · DOI
- Mokshagundam, 1993, Congenital adrenal hyperplasia diagnosed in a man during workup for bilateral adrenal masses., Arch Intern Med, 153, 1389, 10.1001/archinte.1993.00410110083013 · DOI
- Norris, 1996, Macronodular congenital adrenal hyperplasia in an adult with female pseudohermaphroditism., Eur Radiol, 6, 470, 10.1007/BF00182473 · DOI
- Dubey, 1981, A case report of virilising adrenal cortical carcinoma., J Assoc Physicians India, 29, 491
- Bauman, 1982, Virilizing adrenocortical carcinoma. Development in a patient with salt-losing congenital adrenal hyperplasia., JAMA, 248, 3140, 10.1001/jama.1982.03330230052032 · DOI · Paper page
- Lightner, 1993, The adrenal incidentaloma. A pediatric perspective., Am J Dis Child, 147, 1274, 10.1001/archpedi.1993.02160360016002 · DOI
- Terzolo, 1996, Different patterns of steroid secretion in patients with adrenal incidentaloma., J Clin Endocrinol Metab, 81, 740
- Nagasaka, 1996, A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma., Clin Endocrinol (Oxf), 44, 111, 10.1046/j.1365-2265.1996.631456.x · DOI
- Clark, 1990, Steroidogenic enzyme activities, morphology, and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia., J Clin Endocrinol Metab, 70, 1408, 10.1210/jcem-70-5-1408 · DOI
- Avila, 1999, Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings., AJR Am J Roentgenol, 172, 1235, 10.2214/ajr.172.5.10227495 · DOI
- Walker, 1997, Testis sparing surgery for steroid unresponsive testicular tumors of the adrenogenital syndrome., J Urol, 157, 1460, 10.1016/S0022-5347(01)65023-7 · DOI
- Zachmann, 1984, Ovarian steroidogenesis in an adrenalectomized girl with 21-hydroxylase deficiency., Clin Endocrinol (Oxf), 21, 575, 10.1111/j.1365-2265.1984.tb01397.x · DOI
- Srikanth, 1992, Benign testicular tumors in children with congenital adrenal hyperplasia., J Pediatr Surg, 27, 639, 10.1016/0022-3468(92)90466-K · DOI
- Dieckmann, 1995, [Congenital adrenal hyperplasia and testicular hypertrophy]. [French]., Arch Pediatr, 2, 1167, 10.1016/0929-693X(96)89917-9 · DOI
- Solish, 1989, Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia., J Clin Endocrinol Metab, 69, 1148, 10.1210/jcem-69-6-1148 · DOI
- Blumberg-Tick, 1991, Testicular tumors in congenital adrenal hyperplasia: steroid measurements from adrenal and spermatic veins., J Clin Endocrinol Metab, 73, 1129, 10.1210/jcem-73-5-1129 · DOI
- Speiser, 1995, Failure of steroid replacement to consistently normalize pituitary function in congenital adrenal hyperplasia: hormonal and MRI data., Horm Res, 44, 241, 10.1159/000184635 · DOI
- Ghizzoni, 1994, Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children., Metabolism, 43, 372, 10.1016/0026-0495(94)90107-4 · DOI
- Temeck, 1987, Genetic defects of steroidogenesis in premature pubarche., J Clin Endocrinol Metab, 64, 609, 10.1210/jcem-64-3-609 · DOI
- Balducci, 1994, Isolated precocious pubarche: an approach., J Clin Endocrinol Metab, 79, 582
- Marynick, 1983, Androgen excess in cystic acne., N Engl J Med, 308, 981, 10.1056/NEJM198304283081701 · DOI
- Rosenwaks, 1979, An attenuated form of congenital virilizing adrenal hyperplasia., J Clin Endocrinol Metab, 49, 335, 10.1210/jcem-49-3-335 · DOI
- Chrousos, 1981, Unilateral testicular enlargement resulting from inapparent 21-hydroxylase deficiency., J Urol, 126, 127, 10.1016/S0022-5347(17)54411-0 · DOI
- Augarten, 1991, Reversible male infertility in late onset congenital adrenal hyperplasia., J Endocrinol Invest, 14, 237, 10.1007/BF03346799 · DOI
- Kater, 1985, Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency., J Clin Endocrinol Metab, 60, 1057, 10.1210/jcem-60-6-1057 · DOI
- Fiet, 1989, Increased plasma 21-deoxycorticosterone (21-DB) levels in late- onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway., J Clin Endocrinol Metab, 68, 542, 10.1210/jcem-68-3-542 · DOI · Paper page
- Cameron, 1996, Endocrinology and auxology of sibships with non-classical congenital adrenal hyperplasia., Arch Dis Child, 74, 406, 10.1136/adc.74.5.406 · DOI
- Dewailly, 1986, Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency., J Clin Endocrinol Metab, 63, 418, 10.1210/jcem-63-2-418 · DOI · Paper page
- Feldman, 1992, Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency., J Clin Endocrinol Metab, 74, 635
- Laohaprasitiporn, 1996, Induction of ovulation with the sole use of clomiphene citrate in late-onset 21-hydroxylase deficiency., Gynecol Obstet Invest, 41, 224, 10.1159/000292273 · DOI
- Speiser, 1985, High frequency of nonclassical steroid 21-hydroxylase deficiency., Am J Hum Genet, 37, 650
- Sherman, 1988, A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency., Am J Hum Genet, 42, 830
- Dumic, 1990, An update on the frequency of nonclassic deficiency of adrenal 21-hydroxylase in the Yugoslav population., Acta Endocrinol (Copenh), 122, 703, 10.1530/acta.0.1220703 · DOI · Paper page
- Zerah, 1990, Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small sample study., J Clin Endocrinol Metab, 70, 1662, 10.1210/jcem-70-6-1662 · DOI
- Fitness, 1999, Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia., J Clin Endocrinol Metab, 84, 960
- del Balzo, 1992, Adrenal steroidogenic defects in children with precocious pubarche., Horm Res, 37, 180, 10.1159/000182306 · DOI
- Likitmaskul, 1995, ‘Exaggerated adrenarche’ in children presenting with premature adrenarche., Clin Endocrinol (Oxf), 42, 265, 10.1111/j.1365-2265.1995.tb01874.x · DOI
- Ibanez, 1995, Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche., Horm Res, 44, 51, 10.1159/000184592 · DOI
- Lucky, 1986, Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche., J Clin Endocrinol Metab, 62, 840, 10.1210/jcem-62-5-840 · DOI
- Baskin, 1987, Screening for late-onset congenital adrenal hyperplasia in hirsutism or amenorrhea., Arch Intern Med, 147, 847, 10.1001/archinte.1987.00370050043007 · DOI
- Azziz, 1989, 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis., J Clin Endocrinol Metab, 69, 577, 10.1210/jcem-69-3-577 · DOI
- McLaughlin, 1990, Late onset adrenal hyperplasia in a group of Irish females who presented with hirsutism, irregular menses and/or cystic acne., Clin Endocrinol (Oxf), 32, 57, 10.1111/j.1365-2265.1990.tb03750.x · DOI
- Ojeifo, 1984, Basal and adrenocorticotropic hormone-stimulated serum 17α-hydroxyprogesterone in men with idiopathic infertility., Fertil Steril, 42, 97, 10.1016/S0015-0282(16)47965-3 · DOI
- Wischusen, 1981, Reversible male infertility due to congenital adrenal hyperplasia., Clin Endocrinol (Oxf), 14, 571, 10.1111/j.1365-2265.1981.tb02967.x · DOI
- Blanche, 1997, Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women., Hum Genet, 101, 56, 10.1007/s004390050586 · DOI · Paper page
- Knochenhauer, 1997, Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism., J Clin Endocrinol Metab, 82, 479
- Witchel, 1997, Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency., Biochem Mol Med, 62, 151, 10.1006/bmme.1997.2632 · DOI
- Pang, 1985, Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska., Ann NY Acad Sci, 458, 90, 10.1111/j.1749-6632.1985.tb14595.x · DOI
- Lange-Kubini, 1996, 15 beta-hydroxylated steroids may be diagnostically misleading in confirming congenital adrenal hyperplasia suspected by a newborn screening programme., Eur J Pediatr, 155, 928, 10.1007/BF02282880 · DOI
- Nomura, 1997, Immature adrenal steroidogenesis in preterm infants., Early Hum Dev, 49, 225, 10.1016/S0378-3782(97)00037-6 · DOI · Paper page
- Pang, 1982, A pilot newborn screening for congenital adrenal hyperplasia in Alaska., J Clin Endocrinol Metab, 55, 413, 10.1210/jcem-55-3-413 · DOI
- Suwa, 1994, Nationwide survey of neonatal mass-screening for congenital adrenal hyperplasia in Japan., Screening, 3, 141, 10.1016/0925-6164(94)90022-1 · DOI
- Cutfield, 1995, Newborn screening for congenital adrenal hyperplasia in New Zealand., J Pediatr, 126, 118, 10.1016/S0022-3476(95)70513-9 · DOI
- Balsamo, 1996, Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980–1995., Pediatrics, 98, 362
- Brosnan, 1999, Effect of newborn screening for congenital adrenal hyperplasia., Arch Pediatr Adolesc Med, 153, 1272, 10.1001/archpedi.153.12.1272 · DOI · Paper page
- Lebovitz, 1984, Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening., Am J Dis Child, 138, 571, 10.1001/archpedi.1984.02140440055014 · DOI
- Thompson, 1989, Screening for congenital adrenal hyperplasia: distribution of 17α-hydroxyprogesterone concentrations in neonatal blood spot specimens., J Pediatr, 114, 400, 10.1016/S0022-3476(89)80557-8 · DOI
- Thilen, 1990, Congenital adrenal hyperplasia in Sweden 1969–1986. Prevalence, symptoms and age at diagnosis., Acta Paediat Scand, 79, 168, 10.1111/j.1651-2227.1990.tb11434.x · DOI
- Brosnan, 1998, A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas., Public Health Rep, 113, 170
- Gessner, 1996, A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems., Early Hum Dev, 45, 257, 10.1016/0378-3782(96)01761-6 · DOI
- Tajima, 1997, Molecular basis of nonclassical steroid 21-hydroxylase deficiency detected by neonatal mass screening in Japan., J Clin Endocrinol Metab, 82, 2350, 10.1210/jcem.82.7.4094 · DOI
- Nordenstrom, 1999, Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency., J Clin Endocrinol Metab, 84, 1505
- Abdu, 1999, Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease., J Clin Endocrinol Metab, 84, 838
200 of 468 shown
Cited by
Sorted by citations
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Self-citationCongenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Self-citationSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationEstrogen and cognitive functioning in women
Sherwin, B. B. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0016 · Cited by 560
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationGender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia
Dessens, A. B., Slijper, F. M. E., & Drop, S. L. S. (2005) · Archives of Sexual Behavior · doi:10.1007/s10508-005-4338-5 · Cited by 425
Ishimoto, H., & Jaffe, R. B. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0001 · Cited by 379
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., & New, M. I. (2008) · Archives of Sexual Behavior · doi:10.1007/s10508-007-9265-1 · Cited by 326
Minireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Puberty-related influences on brain development
Giedd, J. N., Clasen, L. S., Lenroot, R., Greenstein, D., Wallace, G. L., Ordaz, S., Molloy, E. A., Blumenthal, J. D., Tossell, J. W., Stayer, C., et al. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.016 · Cited by 300
Stikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284
Adrenal insufficiency: still a cause of morbidity and death in childhood
Shulman, D. I., Palmert, M. R., Kemp, S. F., & for the Lawson Wilkins Drug and Therapeutics Committee (2007) · PEDIATRICS · doi:10.1542/peds.2006-1612 · Cited by 282
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
Self-citationNeonatal screening for congenital adrenal hyperplasia
White, P. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.148 · Cited by 240
Self-citationCosta-Santos, M., Kater, C. E., & Auchus, R. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031021 · Cited by 224
11-Oxygenated androgens in health and disease
Turcu, A. F., Rege, J., Auchus, R. J., & Rainey, W. E. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0336-x · Cited by 217
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Tardy, V., Billaud, L., Laborde, K., Coussieu, C., Morel, Y., Vaury, C., Golmard, J.-L., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1582 · Cited by 213
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204
Falhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Forest, M. G. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh047 · Cited by 200
Kamrath, C., Hochberg, Z., Hartmann, M. F., Remer, T., & Wudy, S. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1997 · Cited by 191
Gidlöf, S., Falhammar, H., Thilén, A., von Döbeln, U., Ritzén, M., Wedell, A., & Nordenström, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70007-x · Cited by 187
Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.002 · Cited by 177
Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia
Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0062 · Cited by 174
Self-citationStikkelbroeck, N. M. M. L., Hoefsloot, L. H., de Wijs, I. J., Otten, B. J., Hermus, A. R. M. M., & Sistermans, E. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021681 · Cited by 171
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167
Charmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8456 · Cited by 164
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Fractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151
A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids
Pretorius, E., Arlt, W., & Storbeck, K.-H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.014 · Cited by 142
Hines, M., Pasterski, V., Spencer, D., Neufeld, S., Patalay, P., Hindmarsh, P. C., Hughes, I. A., & Acerini, C. L. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0125 · Cited by 136
Krone, N., Wachter, I., Stefanidou, M., Roscher, A. A., & Schwarz, H. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01359.x · Cited by 135
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Quinkler, M., Meyer, B., Bumke-Vogt, C., Grossmann, C., Gruber, U., Oelkers, W., Diederich, S., & Bahr, V (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460789 · Cited by 130
Krone, N., Rose, I. T., Willis, D. S., Hodson, J., Wild, S. H., Doherty, E. J., Hahner, S., Parajes, S., Stimson, R. H., Han, T. S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3343 · Cited by 119
Falhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Charmandari, E., Hindmarsh, P. C., Johnston, A., & Brook, C. G. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7522 · Cited by 134
Gidlöf, S., Wedell, A., Guthenberg, C., von Döbeln, U., & Nordenström, A. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2013.5321 · Cited by 119
Caulfield, M. P., Lynn, T., Gottschalk, M. E., Jones, K. L., Taylor, N. F., Malunowicz, E. M., Shackleton, C. H. L., Reitz, R. E., & Fisher, D. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8712 · Cited by 120
Katsumata, N., Ohtake, M., Hojo, T., Ogawa, E., Hara, T., Sato, N., & Tanaka, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8763 · Cited by 125
Roche, E. F., Charmandari, E., Dattani, M. T., & Hindmarsh, P. C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01757.x · Cited by 113
Baumgartner-Parzer, S., Witsch-Baumgartner, M., & Hoeppner, W. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0653-5 · Cited by 110
Lin-Su, K., Vogiatzi, M. G., Marshall, I., Harbison, M. D., Macapagal, M. C., Betensky, B., Tansil, S., & New, M. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2128 · Cited by 111
Long-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Bachelot, A., Plu-Bureau, G., Thibaud, E., Laborde, K., Pinto, G., Samara, D., Nihoul-Fékété, C., Kuttenn, F., Polak, M., & Touraine, P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098017 · Cited by 106
Treatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102
Hall, C. M., Jones, J. A., Meyer-Bahlburg, H. F. L., Dolezal, C., Coleman, M., Foster, P., Price, D. A., & Clayton, P. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030696 · Cited by 101
Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia
Lo, J. C., & Grumbach, M. M. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70027-6 · Cited by 98
Bourdeau, I., El Ghorayeb, N., Gagnon, N., & Lacroix, A. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0296 · Cited by 98
Aycan, Z., Bas, V. N., Cetinkaya, S., Yilmaz Agladioglu, S., & Tiryaki, T. (2013) · Clinical Endocrinology · doi:10.1111/cen.12033 · Cited by 98
Marino, R., Ramirez, P., Galeano, J., Perez Garrido, N., Rocco, C., Ciaccio, M., Warman, D. M., Guercio, G., Chaler, E., Maceiras, M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04123.x · Cited by 98
Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency
Auchus, R. J., Buschur, E. O., Chang, A. Y., Hammer, G. D., Ramm, C., Madrigal, D., Wang, G., Gonzalez, M., Xu, X. S., Smit, J. W., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1258 · Cited by 97
Concolino, P., & Costella, A. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0319-y · Cited by 96
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
Pignatelli, D., Carvalho, B. L., Palmeiro, A., Barros, A., Guerreiro, S. G., & Macut, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00432 · Cited by 95
Extraadrenal 21-Hydroxylation by CYP2C19 and CYP3A4: Effect on 21-Hydroxylase Deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1174 · Cited by 91
Chakhtoura, Z., Bachelot, A., Samara-Boustani, D., Ruiz, J.-C., Donadille, B., Dulon, J., Christin-Maître, S., Bouvattier, C., Raux-Demay, M.-C., Bouchard, P., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0887 · Cited by 90
Tajima, T., Okada, T., Ma, X.-M., Ramsey, W. J., Bornstein, S. R., & Aguilera, G. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301018 · Cited by 88
Parajes, S., Quinteiro, C., Domínguez, F., & Loidi, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002138 · Cited by 87
Sciannamblo, M., Russo, G., Cuccato, D., Chiumello, G., & Mora, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2823 · Cited by 82
Monogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
Final Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone
Lin-Su, K., Harbison, M. D., Lekarev, O., Vogiatzi, M. G., & New, M. I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2699 · Cited by 75
Profiles of 21-Carbon Steroids in 21-Hydroxylase Deficiency
Turcu, A. F., Rege, J., Chomic, R., Liu, J., Nishimoto, H. K., Else, T., Moraitis, A. G., Palapattu, G. S., Rainey, W. E., & Auchus, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1023 · Cited by 77
Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies
Kamoun, M., Mnif, M. F., Charfi, N., Kacem, F. H., Naceur, B. B., Mnif, F., Dammak, M., Rekik, N., & Abid, M. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31828aaeee · Cited by 77
Subbarayan, A., Dattani, M. T., Peters, C. J., & Hindmarsh, P. C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12265 · Cited by 73
Bryan, S. M., Honour, J. W., & Hindmarsh, P. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0630 · Cited by 75
Baumgartner-Parzer, S. M., Schulze, E., Waldhäusl, W., Pauschenwein, S., Rondot, S., Nowotny, P., Meyer, K., Frisch, H., Waldhauser, F., & Vierhapper, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7898 · Cited by 74
Kamrath, C., Wettstaedt, L., Boettcher, C., Hartmann, M. F., & Wudy, S. A. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.12.016 · Cited by 71
Stikkelbroeck, N. M. M. L., Hermus, A. R. M. M., Suliman, H. M., Jager, G. J., & Otten, B. J. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.4.645 · Cited by 71
Smeets, E. E. J. W., Span, P. N., van Herwaarden, A. E., Wevers, R. A., Hermus, A. R. M. M., Sweep, F. C. G. J., & Claahsen-van der Grinten, H. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2036 · Cited by 70
Araújo, R. S., Mendonca, B. B., Barbosa, A. S., Lin, C. J., Marcondes, J. A. M., Billerbeck, A. E. C., & Bachega, T. A. S. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2163 · Cited by 70
Riedl, S., Röhl, F.-W., Bonfig, W., Brämswig, J., Richter-Unruh, A., Fricke-Otto, S., Bettendorf, M., Riepe, F., Kriegshäuser, G., Schönau, E., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0281 · Cited by 69
Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia
Sarafoglou, K., Banks, K., Gaviglio, A., Hietala, A., McCann, M., & Thomas, W. (2012) · PEDIATRICS · doi:10.1542/peds.2012-1219 · Cited by 69
Kyriakopoulou, L., Yazdanpanah, M., Colantonio, D. A., Chan, M. K., Daly, C. H., & Adeli, K. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.01.002 · Cited by 68
Tiosano, D., Vlodavsky, E., Filmar, S., Weiner, Z., Goldsher, D., & Bar-Shalom, R. (2010) · Hormone Research in Paediatrics · doi:10.1159/000295722 · Cited by 65
Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013
Heather, N. L., Seneviratne, S. N., Webster, D., Derraik, J. G. B., Jefferies, C., Carll, J., Jiang, Y., Cutfield, W. S., & Hofman, P. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3168 · Cited by 65
Nimkarn, S., Lin-Su, K., Berglind, N., Wilson, R. C., & New, M. I. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0964 · Cited by 63
Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency
Charmandari, E., Eisenhofer, G., Mehlinger, S. L., Carlson, A., Wesley, R., Keil, M. F., Chrousos, G. P., New, M. I., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8664 · Cited by 70
Falhammar, H., & Torpy, D. J. (2016) · Endocrine Practice · doi:10.4158/ep151085.ra · Cited by 63
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
MacKay, D., Nordenström, A., & Falhammar, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00217 · Cited by 59
Rangaswamaiah, S., Gangathimmaiah, V., Nordenstrom, A., & Falhammar, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00493 · Cited by 59
Parajes, S., Kamrath, C., Rose, I. T., Taylor, A. E., Mooij, C. F., Dhir, V., Grötzinger, J., Arlt, W., & Krone, N. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1277 · Cited by 59
Seo, J. Y., Park, H.-D., Kim, J. W., Oh, H. J., Yang, J. S., Chang, Y. S., Park, W. S., & Lee, S.-Y. (2014) · jpme · doi:10.1515/jpm-2013-0154 · Cited by 55
Working memory performance is reduced in children with congenital adrenal hyperplasia
Browne, W. V., Hindmarsh, P. C., Pasterski, V., Hughes, I. A., Acerini, C. L., Spencer, D., Neufeld, S., & Hines, M. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.11.014 · Cited by 54
Congenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Pofi, R., Prete, A., Thornton-Jones, V., Bryce, J., Ali, S. R., Faisal Ahmed, S., Balsamo, A., Baronio, F., Cannuccia, A., Guven, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz055 · Cited by 53
Is physiological glucocorticoid replacement important in children?
Porter, J., Blair, J., & Ross, R. J. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-309538 · Cited by 50
Völkl, T. M. K., Simm, D., Körner, A., Rascher, W., Kiess, W., Kratzsch, J., & Dörr, H. G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0770 · Cited by 49
Pregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome
Eyal, O., Ayalon‐Dangur, I., Segev‐Becker, A., Schachter‐Davidov, A., Israel, S., & Weintrob, N. (2017) · Clinical Endocrinology · doi:10.1111/cen.13429 · Cited by 47
Whitaker, M. J., Spielmann, S., Digweed, D., Huatan, H., Eckland, D., Johnson, T. N., Tucker, G., Krude, H., Blankenstein, O., & Ross, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4060 · Cited by 48
Concolino, P., Mello, E., Minucci, A., Giardina, E., Zuppi, C., Toscano, V., & Capoluongo, E. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-72 · Cited by 47
Ezquieta, B., Cueva, E., Varela, J., Oliver, A., Fernández, J., & Jariego, C. (2002) · Acta Paediatrica · doi:10.1080/080352502760148595 · Cited by 47
Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies
Sarafoglou, K., Barnes, C. N., Huang, M., Imel, E. A., Madu, I.-J., Merke, D. P., Moriarty, D., Nakhle, S., Newfield, R. S., Vogiatzi, M. G., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab438 · Cited by 46
Rocha, R. O., Billerbeck, A. E. C., Pinto, E. M., Melo, K. F. S., Lin, C. J., Longui, C. A., Mendonca, B. B., & Bachega, T. A. S. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03023.x · Cited by 43
Wang, C., Pallan, P. S., Zhang, W., Lei, L., Yoshimoto, F. K., Waterman, M. R., Egli, M., & Guengerich, F. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792465 · Cited by 43
Claahsen-van der Grinten, H. L., Noordam, K., Borm, G. F., & Otten, B. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1701 · Cited by 42
Metadata
- Authors
- White, P. C., & Speiser, P. W.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- North Shore University Hospital (US)
- Corresponding author
- White, Perrin C.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2000-06-01
- Volume
- 21
- Issue
- 3
- Pages
- 245-291
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2148614804
- Cited by
- 1,432
- References
- 62
- Citations by year
- 2026: 16 · 2025: 20 · 2024: 58 · 2023: 47 · 2022: 43 · 2021: 51 · 2020: 57 · 2019: 58 · 2018: 41 · 2017: 99 · 2016: 49 · 2015: 60 · 2014: 69 · 2013: 69 · 2012: 69
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37dk037867-17)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK-37867)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21, intergenic recombination, gene conversion, unequal crossover, salt-wasting crisis, prenatal diagnosis, newborn screening, glucocorticoid replacement therapy, mineralocorticoid replacement, hyperandrogenism, cortisol production
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Glands, Adrenal Hyperplasia, Congenital, Amino Acid Sequence, Base Sequence, Female, Genotype, Glucocorticoids, Humans, Male, Molecular Sequence Data, Mutation, Phenotype, Disorders of Sex Development, Steroid 21-Hydroxylase, Structure-Activity Relationship
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review